. 2015 Dec 17;30(1):51–57. doi: 10.1111/jvim.13800

Table 1.

Demographic data of 64 dogs with MMMVD and CHF separated by AF status

Parameter	AF (n = 33)	No AF (n = 31)	P‐value
Age (year)	11 (6–15)	11 (6–14)	.78
Sex (M/F)	20/13	18/13	.99
BW (kg)	28 (16–64)	22 (16–45)	.016^a
Na (mmol/L)	146 (124–151)	148 (126–154)	.19
K (mmol/L)	4.3 (3.1–4.9)	4.1 (3.2–4.3)	.27
BUN (mg/dL)	34 (11–128)	27 (14–99)	.33
Crea (mg/dL)	1.4 (0.6–2.9)	1.3 (0.8–2.6)	.30
CHF (L/R)	25/8	25/6	.76
Pimobendan (Y/N)	16/17	16/15	.99
Furosemide (mg/kg/day)	6 (3–12)	5.1 (3–15)	.62
Enalapril (Y/N)	30/3	29/2	.91
LA/Ao	2.6 (1.7–3.7)	2.3 (1.8–3.5)	.21
FS%	36 (23–48)	39 (22–55)	.21
Indexed LVESD	3 (2.8–3.3)	2.9 (2.7–3.4)	.13
Survival time (days)	142 (9–478)	234 (13–879)	.002^b

AF = atrial fibrillation; CHF = congestive heart failure; MMMVD = myxomatous mitral valve degeneration; LA = left atrium; Ao = aorta; FS = fractional shortening; LVESD = left ventricular end‐systolic diameter; BUN = blood urea nitrogen; BW = body weight; M = male; F = female; BUN = blood urea nitrogen; Crea = creatinine; Na = sodium; K = potassium. Median (range) or proportion is reported.

P < .05.

P < .01.